Blanchard JM - Search Results

1

Cyclin E drives human keratinocyte growth into differentiation.

Freije A, Ceballos L, Coisy M, Barnes L, Rosa M, De Diego E, Blanchard JM, Gandarillas A. Freije A, et al. Among authors: blanchard jm. Oncogene. 2012 Dec 13;31(50):5180-92. doi: 10.1038/onc.2012.22. Epub 2012 Feb 20. Oncogene. 2012. PMID: 22349815

2

Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication.

Gandarillas A, Davies D, Blanchard JM. Gandarillas A, et al. Among authors: blanchard jm. Oncogene. 2000 Jul 6;19(29):3278-89. doi: 10.1038/sj.onc.1203630. Oncogene. 2000. PMID: 10918584

3

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size.

Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A. Dazard JE, et al. Among authors: blanchard jm. Oncogene. 2000 Aug 3;19(33):3693-705. doi: 10.1038/sj.onc.1203695. Oncogene. 2000. PMID: 10949923

4

Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2alpha.

Coisy M, Roure V, Ribot M, Philips A, Muchardt C, Blanchard JM, Dantonel JC. Coisy M, et al. Among authors: blanchard jm. Mol Cell. 2004 Jul 2;15(1):43-56. doi: 10.1016/j.molcel.2004.06.022. Mol Cell. 2004. PMID: 15225547 Free article.

5

Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation.

Basset-Séguin N, Demoly P, Moles JP, Tesnières A, Gauthier-Rouvière C, Richard S, Blanchard JM, Guilhou JJ. Basset-Séguin N, et al. Among authors: blanchard jm. Oncogene. 1994 Mar;9(3):765-71. Oncogene. 1994. PMID: 8108118

6

Anchorage-dependent expression of cyclin A in primary cells requires a negative DNA regulatory element and a functional Rb.

Philips A, Huet X, Plet A, Rech J, Vié A, Blanchard JM. Philips A, et al. Among authors: blanchard jm. Oncogene. 1999 Mar 11;18(10):1819-25. doi: 10.1038/sj.onc.1202530. Oncogene. 1999. PMID: 10086336

7

Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules.

Plet A, Huet X, Algarté M, Rech J, Imbert J, Philips A, Blanchard JM. Plet A, et al. Among authors: blanchard jm. Oncogene. 1997 May 29;14(21):2575-83. doi: 10.1038/sj.onc.1201103. Oncogene. 1997. PMID: 9191057

8

Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase.

Darbon JM, Devault A, Taviaux S, Fesquet D, Martinez AM, Galas S, Cavadore JC, Dorée M, Blanchard JM. Darbon JM, et al. Among authors: blanchard jm. Oncogene. 1994 Nov;9(11):3127-38. Oncogene. 1994. PMID: 7936635

9

The retinoblastoma protein is essential for cyclin A repression in quiescent cells.

Philips A, Huet X, Plet A, Le Cam L, Vié A, Blanchard JM. Philips A, et al. Among authors: blanchard jm. Oncogene. 1998 Mar;16(11):1373-81. doi: 10.1038/sj.onc.1201655. Oncogene. 1998. PMID: 9525736

10

To be or not to be a proliferation marker?

Blanchard JM. Blanchard JM. Oncogene. 2014 Feb 20;33(8):954-5. doi: 10.1038/onc.2013.19. Epub 2013 Feb 11. Oncogene. 2014. PMID: 23396366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters